Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05950633 · ClinicalTrials.gov registry record · NA
Postoperative Active Recovery
A NA study of Pelvic Floor Disorders, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT05950633: Completed NA study of Pelvic Floor Disorders, sponsored by Oregon Health and Science University.
NCT05950633 is a NA study of Pelvic Floor Disorders that has completed, run by Oregon Health and Science University. The registered enrollment target is 72 participants, below the 110-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05950633, a NA study of Pelvic Floor Disorders, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study evaluating a novel active recovery program in the immediate postoperative period following pelvic reconstructive surgery.
Primary Outcome
The change in the Pelvic Floor Distress Inventory-20 (PFDI-20) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate how much symptoms bother them from 0 (not at all) to 4 (quite a bit)
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER Active Recovery
Study Locations (1)
Oregon
- OHSU - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT05950633 record still lists
NCT05950633 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 110-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Pelvic Floor Disorders appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT05950633 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05950633 about?
NCT05950633 is a clinical study titled "Postoperative Active Recovery". This is a study evaluating a novel active recovery program in the immediate postoperative period following pelvic reconstructive surgery.
What is the current status of trial NCT05950633?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2023-09-01. Estimated completion is 2025-07-31.
What conditions does trial NCT05950633 study?
This clinical trial studies the following conditions: Pelvic Floor Disorders.
What interventions are being tested in trial NCT05950633?
The interventions under investigation include: Standard of Care (OTHER), Active Recovery (OTHER).
Who is sponsoring clinical trial NCT05950633?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05950633 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Floor Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05950633's enrollment target sits among peer trials
72 7th of 11 higher than 4 of 11 other Pelvic Floor Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Floor Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.
RECRUITING · NA
-
Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy
RECRUITING · NA
-
Improving Women's Function After Pelvic Radiation
ACTIVE NOT RECRUITING · NA
-
Pudendal Nerve Block in Vaginal Surgery
COMPLETED · NA
-
Satisfaction of Limited English-Proficient Patients With Phone Interpretation Services Compared to In-Person Interpreters: A Randomized Controlled Trial
COMPLETED · NA
-
Pelvic Floor Physical Therapy vs Standard Care in Transgender Women Undergoing Vaginoplasty for Gender Affirmation
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI